Back
Nano-X investors face Aug. 11, 2026 lead plaintiff deadline in class action

Nano-X investors face Aug. 11, 2026 lead plaintiff deadline in class action

Investors who bought NNOX securities during the March 31, 2025 to April 17, 2026 class period face an Aug. 11 deadline after restructuring, impairment and demand-alignment disclosures triggered a 24.39% share drop.

Fact Check
The Rosen Law Firm release confirms the August 11, 2026 deadline, the March 31, 2025 – April 17, 2026 class period, and allegations concerning demand, efficiency gains, and cash burn. The Pomerantz release independently confirms the same deadline and class period, and specifies the corrective disclosure on April 20, 2026 with a 24.39% stock drop (matching the claimed 24.4%). Independent law firms (Kessler Topaz, Levi & Korsinsky) corroborate the class period and deadline. All key facts of the claim are supported.
Summary

Nano-X Imaging Ltd. (NASDAQ: NNOX) investors who purchased securities from March 31, 2025 through April 17, 2026 have until Aug. 11, 2026 to seek appointment as lead plaintiff in a proposed securities class action alleging the company misled the market about manufacturing efficiency, product demand, operating expenses, cash burn and financial condition. The complaint says the alleged problems surfaced on April 20, 2026, when Nano-X reported a fourth-quarter 2025 net loss of $33.4 million, including a $17.5 million impairment charge tied to long-lived assets after restructuring its Korean chip manufacturing facility, said it was shifting toward a more efficient outsourced production model better aligned with current and anticipated demand, and said its then-Chief Financial Officer would step down effective July 31, 2026. Nano-X shares fell $0.695, or about 24.39%, to close at $2.155 that day.

Terms & Concepts
  • lead plaintiff: An investor appointed by the court to act on behalf of the proposed class in a securities lawsuit.
  • securities class action: A lawsuit filed on behalf of a group of investors who claim they were harmed by the same alleged securities-law violations.
  • impairment charge: An accounting write-down that reduces the recorded value of an asset when it is deemed less valuable than previously reported.